Minimal difference in phenotype between adolescents and young adults with polycystic ovary syndrome

Temeka Zore, Daria Lizneva, Soumia Brakta, Walidah Walker, Larisa Suturina, Ricardo Azziz

Research output: Contribution to journalArticle

Abstract

Objective: To test the hypothesis that the polycystic ovary syndrome (PCOS) phenotype, or its component features, is less severe in adolescents than in young adult patients, in a referred (clinical) population. Design: Cross-sectional study. Setting: Tertiary-care academic medical center. Patient(s): Two hundred seventy-four adolescents and young adults aged 13.0–24.9 years with PCOS according to the National Institute of Health 1990 criteria. Patients were categorized as adolescents (AD: 13.0–18.9 years; n = 91) and young adults (YA: 19.0–24.9 years; n = 183). Adolescents were further categorized as early adolescents (Early-AD: 13.0–15.9 years; n = 31) and late adolescents (Late-AD: 16.0–18.9 years; n = 60). Intervention(s): History, physical examination, hormonal assays with the use of standardized protocols. Main Outcome Measure(s): Unadjusted and adjusted odds ratios (ORs; adjusted for body mass index [BMI] when applicable) were calculated for biochemical hyperandrogenism (HA), hirsutism (HIR), acne, and degree of oligo/amenorrhea (OA). PCOS phenotypes were classified as HIR+HA+OA, HA+OA, and HIR+OA. Result(s): Our analysis demonstrated minimal significant difference in the prevalence of the three PCOS phenotypes, or component features, between AD and YA patients. The risks for obesity were higher for YA versus AD, and the risk of acne was lower for YA versus AD. There was no significant difference between Early-AD and Late-AD. BMI-adjusted models did not significantly modify the main findings. Conclusion(s): The present study suggests that the PCOS phenotype is established in early adolescence, remains constant into adulthood, and is not related to BMI.

Original languageEnglish (US)
Pages (from-to)389-396
Number of pages8
JournalFertility and sterility
Volume111
Issue number2
DOIs
StatePublished - Feb 2019

Fingerprint

Polycystic Ovary Syndrome
Young Adult
Phenotype
Amenorrhea
Hyperandrogenism
Hirsutism
Body Mass Index
Acne Vulgaris
National Institutes of Health (U.S.)
Tertiary Healthcare
Physical Examination
Obesity
Cross-Sectional Studies
History
Odds Ratio
Outcome Assessment (Health Care)
Population

Keywords

  • PCOS
  • adolescents
  • obesity
  • phenotypes

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Minimal difference in phenotype between adolescents and young adults with polycystic ovary syndrome. / Zore, Temeka; Lizneva, Daria; Brakta, Soumia; Walker, Walidah; Suturina, Larisa; Azziz, Ricardo.

In: Fertility and sterility, Vol. 111, No. 2, 02.2019, p. 389-396.

Research output: Contribution to journalArticle

Zore, Temeka ; Lizneva, Daria ; Brakta, Soumia ; Walker, Walidah ; Suturina, Larisa ; Azziz, Ricardo. / Minimal difference in phenotype between adolescents and young adults with polycystic ovary syndrome. In: Fertility and sterility. 2019 ; Vol. 111, No. 2. pp. 389-396.
@article{78ca15d425a3440c8107c4af516e19fc,
title = "Minimal difference in phenotype between adolescents and young adults with polycystic ovary syndrome",
abstract = "Objective: To test the hypothesis that the polycystic ovary syndrome (PCOS) phenotype, or its component features, is less severe in adolescents than in young adult patients, in a referred (clinical) population. Design: Cross-sectional study. Setting: Tertiary-care academic medical center. Patient(s): Two hundred seventy-four adolescents and young adults aged 13.0–24.9 years with PCOS according to the National Institute of Health 1990 criteria. Patients were categorized as adolescents (AD: 13.0–18.9 years; n = 91) and young adults (YA: 19.0–24.9 years; n = 183). Adolescents were further categorized as early adolescents (Early-AD: 13.0–15.9 years; n = 31) and late adolescents (Late-AD: 16.0–18.9 years; n = 60). Intervention(s): History, physical examination, hormonal assays with the use of standardized protocols. Main Outcome Measure(s): Unadjusted and adjusted odds ratios (ORs; adjusted for body mass index [BMI] when applicable) were calculated for biochemical hyperandrogenism (HA), hirsutism (HIR), acne, and degree of oligo/amenorrhea (OA). PCOS phenotypes were classified as HIR+HA+OA, HA+OA, and HIR+OA. Result(s): Our analysis demonstrated minimal significant difference in the prevalence of the three PCOS phenotypes, or component features, between AD and YA patients. The risks for obesity were higher for YA versus AD, and the risk of acne was lower for YA versus AD. There was no significant difference between Early-AD and Late-AD. BMI-adjusted models did not significantly modify the main findings. Conclusion(s): The present study suggests that the PCOS phenotype is established in early adolescence, remains constant into adulthood, and is not related to BMI.",
keywords = "PCOS, adolescents, obesity, phenotypes",
author = "Temeka Zore and Daria Lizneva and Soumia Brakta and Walidah Walker and Larisa Suturina and Ricardo Azziz",
year = "2019",
month = "2",
doi = "10.1016/j.fertnstert.2018.10.020",
language = "English (US)",
volume = "111",
pages = "389--396",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Minimal difference in phenotype between adolescents and young adults with polycystic ovary syndrome

AU - Zore, Temeka

AU - Lizneva, Daria

AU - Brakta, Soumia

AU - Walker, Walidah

AU - Suturina, Larisa

AU - Azziz, Ricardo

PY - 2019/2

Y1 - 2019/2

N2 - Objective: To test the hypothesis that the polycystic ovary syndrome (PCOS) phenotype, or its component features, is less severe in adolescents than in young adult patients, in a referred (clinical) population. Design: Cross-sectional study. Setting: Tertiary-care academic medical center. Patient(s): Two hundred seventy-four adolescents and young adults aged 13.0–24.9 years with PCOS according to the National Institute of Health 1990 criteria. Patients were categorized as adolescents (AD: 13.0–18.9 years; n = 91) and young adults (YA: 19.0–24.9 years; n = 183). Adolescents were further categorized as early adolescents (Early-AD: 13.0–15.9 years; n = 31) and late adolescents (Late-AD: 16.0–18.9 years; n = 60). Intervention(s): History, physical examination, hormonal assays with the use of standardized protocols. Main Outcome Measure(s): Unadjusted and adjusted odds ratios (ORs; adjusted for body mass index [BMI] when applicable) were calculated for biochemical hyperandrogenism (HA), hirsutism (HIR), acne, and degree of oligo/amenorrhea (OA). PCOS phenotypes were classified as HIR+HA+OA, HA+OA, and HIR+OA. Result(s): Our analysis demonstrated minimal significant difference in the prevalence of the three PCOS phenotypes, or component features, between AD and YA patients. The risks for obesity were higher for YA versus AD, and the risk of acne was lower for YA versus AD. There was no significant difference between Early-AD and Late-AD. BMI-adjusted models did not significantly modify the main findings. Conclusion(s): The present study suggests that the PCOS phenotype is established in early adolescence, remains constant into adulthood, and is not related to BMI.

AB - Objective: To test the hypothesis that the polycystic ovary syndrome (PCOS) phenotype, or its component features, is less severe in adolescents than in young adult patients, in a referred (clinical) population. Design: Cross-sectional study. Setting: Tertiary-care academic medical center. Patient(s): Two hundred seventy-four adolescents and young adults aged 13.0–24.9 years with PCOS according to the National Institute of Health 1990 criteria. Patients were categorized as adolescents (AD: 13.0–18.9 years; n = 91) and young adults (YA: 19.0–24.9 years; n = 183). Adolescents were further categorized as early adolescents (Early-AD: 13.0–15.9 years; n = 31) and late adolescents (Late-AD: 16.0–18.9 years; n = 60). Intervention(s): History, physical examination, hormonal assays with the use of standardized protocols. Main Outcome Measure(s): Unadjusted and adjusted odds ratios (ORs; adjusted for body mass index [BMI] when applicable) were calculated for biochemical hyperandrogenism (HA), hirsutism (HIR), acne, and degree of oligo/amenorrhea (OA). PCOS phenotypes were classified as HIR+HA+OA, HA+OA, and HIR+OA. Result(s): Our analysis demonstrated minimal significant difference in the prevalence of the three PCOS phenotypes, or component features, between AD and YA patients. The risks for obesity were higher for YA versus AD, and the risk of acne was lower for YA versus AD. There was no significant difference between Early-AD and Late-AD. BMI-adjusted models did not significantly modify the main findings. Conclusion(s): The present study suggests that the PCOS phenotype is established in early adolescence, remains constant into adulthood, and is not related to BMI.

KW - PCOS

KW - adolescents

KW - obesity

KW - phenotypes

UR - http://www.scopus.com/inward/record.url?scp=85057577844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057577844&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2018.10.020

DO - 10.1016/j.fertnstert.2018.10.020

M3 - Article

C2 - 30527835

AN - SCOPUS:85057577844

VL - 111

SP - 389

EP - 396

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 2

ER -